
SIPM- CAS
Suzhou Institute of Pharmaceutical Sciences, Chinese Academy of Sciences
BACKGROUND
SIMM
The Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences is China’s oldest comprehensive innovative drug research institution. It was originally established in 1932 as the Institute of Materia Medica under the National Academy of Peiping. Today, it is located in the Zhangjiang Hi-Tech Park in Pudong, Shanghai.
SIMM-SIP
To strengthen its strategic presence in biopharmaceutical research and development, SIMM partnered with the Suzhou Industrial Park (SIP) government in October 2014 to establish the Suzhou Institute of Pharmaceutical Sciences (SIPM-CAS). The institute was officially founded in August 2015 and is committed to building a world-class research hub for biopharmaceutical innovation, promoting the development of China’s pharmaceutical industry.
SIPM-CAS
The researchers at SIPM-CAS typically hold Ph.D. degrees in pharmacy, chemistry, biology, or related disciplines and have extensive research experience in prestigious universities or research institutions worldwide. They specialize in various fields such as medicinal chemistry, drug metabolism, and pharmacology, making significant contributions to their respective areas. Additionally, the institute actively recruits top talents with backgrounds in biomaterials, medicinal chemistry, or cell biology to further strengthen its research teams.

IDROTIDE
SIPM-CAS unites a global scientific elite, with over 80% of researchers holding PhDs from top 50 global universities and institutions, specializing in medicinal chemistry, pharmacokinetics, biomaterials, and emerging disciplines. Through a dynamic talent network, it integrates expertise in computational drug design, gene editing, and organoid technologies to drive end-to-end innovation from target discovery to clinical translation.
IDROTIDE LTD specializes in raw material supply (cosmetics, chemicals, medical devices) and production equipment sales (medical devices, gel patch equipment), serving high-growth industries.